1. Unit 465, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
2. Unit 341, INSERM, Hôtel-Dieu, Paris, France
3. Unit 545, INSERM, Département d’Athérosclérose, Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France
4. Pacific Northwest Research Institute and the Department of Medicine, University of Washington, Seattle, Washington
5. Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland